Skip to main content
Signal8

Bae Hyun W.

SEC insider (Form 3/4/5 filer). CIK 0001988551. Director at Kairos Pharma, LTD. (KAPA). 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 8, 2025. Located in LOS ANGELES, CA.

Companies Bae Hyun W. has filed insider reports for

  • Kairos Pharma, LTD. (KAPA): Director
Bae Hyun W. profile photo

Bae Hyun W.

CIK: 0001988551

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Kairos Pharma, LTD. logo
KAPA

Kairos Pharma, LTD.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Kairos Pharma, LTD. logo
    KAPA

    Kairos Pharma, LTD.

    Oct 8, 2025
    Award
    Direct
    19.1K shares-
  • Kairos Pharma, LTD. logo
    KAPA

    Kairos Pharma, LTD.

    Sep 16, 2025
    Award
    Direct
    10K shares-

1-2 of 2